BeStock  
Stocks › OBX

Obsidian Therapeutics OBX

US equityMarket cap rank #3348
$12.00 −$0.15 (-1.23%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $12.00 0.00%
Open$12.01
Prev close$12.15
Day range$11.76 – $12.30
Volume336.5K
Market cap$741.29M
P/E (TTM)18.5
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings19.3x
CheapRich

Below its usual level · 34th percentile, 5-year average 16.4x

#1565 of 2991 stocks by PE (1 = cheapest)

Price / book2.4x
CheapRich

Below its usual level · 35th percentile, 5-year average 2.8x

#3417 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-29x0x29x58xAug '26Sep '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$17.87
Price vs. fair value-32.8%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.42 – 2.84 35% (cheaper than usual) #3417 of 5329 (1 = cheapest)
PE 19.32 -4.33 16.42 34% (cheaper than usual) #1565 of 2991 (1 = cheapest)
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on OBX.

Sign in to join the discussion.

Scroll to Top